Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.169 USD | +0.60% |
|
+0.36% | +20.71% |
May. 20 | Elite Pharmaceuticals Receives Fda Approval for Generic Methotrexate | CI |
Feb. 15 | Transcript : Elite Pharmaceuticals, Inc., Q3 2024 Earnings Call, Feb 15, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ELITE PHARMACEUTICALS, INC. | Generic Pharmaceuticals | +0.60% | +0.36% | +20.71% | +412.12% | +188.89% | 181M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- ELTP Stock
- Charts Elite Pharmaceuticals, Inc.
- Comparison Chart